Stay updated on Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.5.4 was added and v3.5.3 was removed, indicating an internal update to the page's template/versioning. There are no changes described to displayed study information.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, indicating a minor update to the page's versioning rather than substantive changes to the study details.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check83 days agoChange DetectedThe revision is updated to v3.4.3, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check111 days agoChange DetectedAdded Revision: v3.4.2 and removed the government-funding operating-status notice and prior revision (v3.4.1); these are administrative site updates that do not alter study content, endpoints, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.